Your browser doesn't support javascript.
loading
The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
Wright, N C; Saag, K G; Dawson-Hughes, B; Khosla, S; Siris, E S.
  • Wright NC; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Saag KG; Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Dawson-Hughes B; USDA Human Nutrition Research Center at Tufts University, Medford, MA, USA.
  • Khosla S; Division of Endocrinology, Metabolism, Diabetes, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Siris ES; Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY, USA. es27@cumc.columbia.edu.
Osteoporos Int ; 28(11): 3283-3284, 2017 11.
Article en En | MEDLINE | ID: mdl-28936598
ABSTRACT
We evaluated the prevalence of osteoporosis using the osteoporosis diagnostic criteria developed by the National Bone Health Alliance (NBHA), which includes qualified fractures, FRAX score in addition to BMD. The expanded definition increases the prevalence compared to BMD alone definitions; however, it may better identify those at elevated fracture risk. Recently an NBHA working Group published a paper in OI with recommendations for expanding the criteria that would constitute an osteoporosis diagnosis in postmenopausal women and in men over age 50 for use in the US - Siris et al., Osteoporosis International 25(%) 1439-1443, 2014. The recommendations have now been endorsed by NOF, ASBMR and a number of professional medical groups and appear in the NOF Clinician's Guide. The new diagnostic criteria continue to include a T-score by DXA of spine or hip that is less than or equal to -2.5, but alternatively also include a hip fracture with or without BMD testing or a vertebral, pelvis, proximal humerus and in some cases a distal forearm fracture in a person with low bone mass, or a FRAX score that meets or exceeds the NOF Guide osteoporosis treatment cut point.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoporosis Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: America do norte Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Osteoporosis Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: America do norte Idioma: En Año: 2017 Tipo del documento: Article